Dibba, P.; Li, A.; Cholankeril, G.; Iqbal, U.; Gadiparthi, C.; Khan, M.A.; Kim, D.; Ahmed, A.
Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease. Medicines 2018, 5, 47.
https://doi.org/10.3390/medicines5020047
AMA Style
Dibba P, Li A, Cholankeril G, Iqbal U, Gadiparthi C, Khan MA, Kim D, Ahmed A.
Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease. Medicines. 2018; 5(2):47.
https://doi.org/10.3390/medicines5020047
Chicago/Turabian Style
Dibba, Pratima, Andrew Li, George Cholankeril, Umair Iqbal, Chiranjeevi Gadiparthi, Muhammad Ali Khan, Donghee Kim, and Aijaz Ahmed.
2018. "Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease" Medicines 5, no. 2: 47.
https://doi.org/10.3390/medicines5020047
APA Style
Dibba, P., Li, A., Cholankeril, G., Iqbal, U., Gadiparthi, C., Khan, M. A., Kim, D., & Ahmed, A.
(2018). Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease. Medicines, 5(2), 47.
https://doi.org/10.3390/medicines5020047